tiprankstipranks
Trending News
More News >
Collegium Pharmaceutical (COLL)
NASDAQ:COLL
US Market
Advertisement

Collegium Pharmaceutical (COLL) Ratios

Compare
475 Followers

Collegium Pharmaceutical Ratios

COLL's free cash flow for Q1 2025 was $0.55. For the 2025 fiscal year, COLL's free cash flow was decreased by $ and operating cash flow was $0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.08 1.17 1.55 1.37 1.45
Quick Ratio
1.01 1.10 1.38 1.29 1.37
Cash Ratio
0.20 0.52 0.64 0.81 0.91
Solvency Ratio
0.17 0.21 0.11 0.29 0.19
Operating Cash Flow Ratio
0.41 0.60 0.46 0.45 0.49
Short-Term Operating Cash Flow Coverage
3.07 1.50 0.76 2.11 1.95
Net Current Asset Value
$ -869.40M$ -410.28M$ -559.30M$ -173.61M$ -179.92M
Leverage Ratios
Debt-to-Assets Ratio
0.52 0.59 0.74 0.37 0.41
Debt-to-Equity Ratio
3.60 3.45 4.48 1.28 1.43
Debt-to-Capital Ratio
0.78 0.78 0.82 0.56 0.59
Long-Term Debt-to-Capital Ratio
0.77 0.71 0.73 0.50 0.53
Financial Leverage Ratio
6.96 5.85 6.03 3.41 3.46
Debt Service Coverage Ratio
2.19 1.05 0.76 2.30 1.52
Interest Coverage Ratio
1.84 2.00 -1.65 -2.22 -0.18
Debt to Market Cap
0.82 0.64 0.89 0.38 0.37
Interest Debt Per Share
28.99 22.45 27.67 8.01 8.59
Net Debt to EBITDA
2.25 1.41 4.14 0.84 0.78
Profitability Margins
Gross Profit Margin
57.69%57.55%45.15%54.40%58.01%
EBIT Margin
21.45%28.07%7.41%6.37%18.21%
EBITDA Margin
50.10%54.40%36.38%31.27%38.09%
Operating Profit Margin
21.39%29.46%-22.54%-16.87%-1.64%
Pretax Profit Margin
9.80%13.36%-6.22%-1.22%8.90%
Net Profit Margin
6.61%8.50%-5.39%25.83%8.63%
Continuous Operations Profit Margin
6.61%8.50%-5.39%25.83%8.63%
Net Income Per EBT
67.46%63.59%86.67%-2119.65%96.99%
EBT Per EBIT
45.79%45.36%27.59%7.22%-542.31%
Return on Assets (ROA)
2.69%4.21%-2.13%10.33%4.16%
Return on Equity (ROE)
19.21%24.64%-12.83%35.24%14.38%
Return on Capital Employed (ROCE)
12.41%24.36%-11.57%-10.12%-1.12%
Return on Invested Capital (ROIC)
7.92%12.21%-8.48%193.46%-0.98%
Return on Tangible Assets
6.81%8.19%-5.29%16.89%8.69%
Earnings Yield
4.31%4.64%-3.19%10.96%3.88%
Efficiency Ratios
Receivables Turnover
2.90 3.16 2.53 2.62 3.72
Payables Turnover
15.74 27.68 72.82 30.14 13.00
Inventory Turnover
7.55 7.44 5.47 7.26 8.34
Fixed Asset Turnover
34.25 25.75 17.59 10.20 11.32
Asset Turnover
0.41 0.50 0.40 0.40 0.48
Working Capital Turnover Ratio
97.76 4.94 3.95 3.22 4.27
Cash Conversion Cycle
150.82 151.48 205.76 177.71 113.79
Days of Sales Outstanding
125.67 115.61 144.07 139.54 98.10
Days of Inventory Outstanding
48.33 49.05 66.71 50.29 43.78
Days of Payables Outstanding
23.18 13.19 5.01 12.11 28.08
Operating Cycle
174.00 164.66 210.77 189.82 141.88
Cash Flow Ratios
Operating Cash Flow Per Share
6.24 8.14 3.67 2.96 2.73
Free Cash Flow Per Share
6.18 8.13 3.62 2.91 -8.13
CapEx Per Share
0.06 0.01 0.05 0.06 10.86
Free Cash Flow to Operating Cash Flow
0.99 1.00 0.99 0.98 -2.98
Dividend Paid and CapEx Coverage Ratio
105.44 595.98 76.59 53.27 0.25
Capital Expenditure Coverage Ratio
105.44 595.98 76.59 53.27 0.25
Operating Cash Flow Coverage Ratio
0.24 0.41 0.14 0.40 0.35
Operating Cash Flow to Sales Ratio
0.30 0.48 0.27 0.37 0.30
Free Cash Flow Yield
19.11%26.41%15.62%15.57%-40.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
23.16 21.57 -31.39 9.13 25.76
Price-to-Sales (P/S) Ratio
1.55 1.83 1.69 2.36 2.22
Price-to-Book (P/B) Ratio
4.34 5.31 4.03 3.22 3.70
Price-to-Free Cash Flow (P/FCF) Ratio
5.23 3.79 6.40 6.42 -2.46
Price-to-Operating Cash Flow Ratio
5.12 3.78 6.32 6.30 7.34
Price-to-Earnings Growth (PEG) Ratio
-0.65 -0.07 0.23 0.06 -0.06
Price-to-Fair Value
4.34 5.31 4.03 3.22 3.70
Enterprise Value Multiple
5.34 4.78 8.79 8.37 6.62
Enterprise Value
1.78B 1.47B 1.48B 724.94M 781.66M
EV to EBITDA
5.34 4.78 8.79 8.37 6.62
EV to Sales
2.67 2.60 3.20 2.62 2.52
EV to Free Cash Flow
9.04 5.37 12.10 7.13 -2.79
EV to Operating Cash Flow
8.95 5.36 11.95 7.00 8.32
Tangible Book Value Per Share
-23.66 -10.67 -14.97 -1.88 -4.36
Shareholders’ Equity Per Share
7.37 5.79 5.76 5.81 5.41
Tax and Other Ratios
Effective Tax Rate
0.33 0.36 0.13 22.20 0.03
Revenue Per Share
20.89 16.80 13.71 7.92 9.01
Net Income Per Share
1.38 1.43 -0.74 2.05 0.78
Tax Burden
0.67 0.64 0.87 -21.20 0.97
Interest Burden
0.46 0.48 -0.84 -0.19 0.49
Research & Development to Revenue
0.00 0.00 <0.01 0.03 0.03
SG&A to Revenue
0.00 0.27 0.35 0.41 0.35
Stock-Based Compensation to Revenue
0.05 0.05 0.05 0.09 0.07
Income Quality
4.52 5.71 -4.97 1.45 3.51
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis